Literature DB >> 24344761

Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome.

Anne Line Engsbro1, Christen Rune Stensvold, Henrik Vedel Nielsen, Peter Bytzer.   

Abstract

The gut microbiota may be involved in the aetiopathogenesis of irritable bowel syndrome (IBS). We studied the role of intestinal parasites by describing the epidemiology and risk factors for infection in primary care patients aged 18-50 y with IBS. One hundred and thirty-eight patients at baseline and 78/116 patients returning 1 y later, submitted faecal samples that were examined by microscopy, culture for Blastocystis, and real-time PCR for Dientamoeba fragilis, Entamoeba (dispar and histolytica), Cryptosporidium spp., and Giardia intestinalis. Overall, 42-45% of patients harboured intestinal parasites (baseline and follow-up, respectively): D. fragilis carriage was 35-41%; Blastocystis 14-20%. Incidence rates for D. fragilis and Blastocystis were 10 and 4 per 100 person-y, respectively. Blastocystis carriage increased the odds for carrying D. fragilis. Clinical comparisons showed D. fragilis to be associated with a low frequency of defecation. Further, D. fragilis was associated with having children aged 5-18 y and Blastocystis with increasing age.

Entities:  

Mesh:

Year:  2013        PMID: 24344761     DOI: 10.3109/00365548.2013.861609

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

Review 1.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

Review 2.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Collecting Fecal Samples for Microbiome Analyses in Epidemiology Studies.

Authors:  Rashmi Sinha; Jun Chen; Amnon Amir; Emily Vogtmann; Jianxin Shi; Kristin S Inman; Roberto Flores; Joshua Sampson; Rob Knight; Nicholas Chia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-24       Impact factor: 4.254

4.  Low prevalence of Blastocystis sp. in active ulcerative colitis patients.

Authors:  N G Rossen; A Bart; N Verhaar; E van Nood; R Kootte; P F de Groot; G R D'Haens; C Y Ponsioen; T van Gool
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 3.267

5.  Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.

Authors:  Laura Rindom Krogsgaard; Lee O 'Brien Andersen; Thor Bech Johannesen; Anne Line Engsbro; Christen Rune Stensvold; Henrik Vedel Nielsen; Peter Bytzer
Journal:  Clin Transl Gastroenterol       Date:  2018-06-19       Impact factor: 4.488

Review 6.  What is the importance of zoonotic trichomonads for human health?

Authors:  Julia M Maritz; Kirkwood M Land; Jane M Carlton; Robert P Hirt
Journal:  Trends Parasitol       Date:  2014-06-18

7.  The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites.

Authors:  Jason Blitz; Mark S Riddle; Chad K Porter
Journal:  Front Microbiol       Date:  2018-01-23       Impact factor: 5.640

8.  Prevalence and Risk Factors of Human Intestinal Parasites in Roudehen, Tehran Province, Iran.

Authors:  Nasrin Hemmati; Elham Razmjou; Saeideh Hashemi-Hafshejani; Abbas Motevalian; Lameh Akhlaghi; Ahmad Reza Meamar
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

9.  Protozoan parasites in irritable bowel syndrome: A case-control study.

Authors:  Khaled A Jadallah; Laila F Nimri; Rola A Ghanem
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-11-06

10.  Prevalence and associated risk factors of human intestinal parasitic infections: a population-based study in the southeast of Kerman province, southeastern Iran.

Authors:  Mohammad Javad Abbaszadeh Afshar; Maryam Barkhori Mehni; Mostafa Rezaeian; Mehdi Mohebali; Vali Baigi; Somayeh Amiri; Mohammad Bagher Amirshekari; Ruhollah Hamidinia; Mohammad Samimi
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.